RxSight (RXST) Accumulated Depreciation & Amortization (2020 - 2024)
Historic Accumulated Depreciation & Amortization for RxSight (RXST) over the last 5 years, with Q4 2024 value amounting to $3.6 million.
- RxSight's Accumulated Depreciation & Amortization fell 1219.51% to $3.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $3.6 million, marking a year-over-year decrease of 1219.51%. This contributed to the annual value of $3.6 million for FY2024, which is 1219.51% down from last year.
- According to the latest figures from Q4 2024, RxSight's Accumulated Depreciation & Amortization is $3.6 million, which was down 1219.51% from $4.1 million recorded in Q4 2023.
- In the past 5 years, RxSight's Accumulated Depreciation & Amortization registered a high of $4.1 million during Q4 2023, and its lowest value of $3.6 million during Q4 2024.
- In the last 5 years, RxSight's Accumulated Depreciation & Amortization had a median value of $3.9 million in 2020 and averaged $3.9 million.
- In the last 5 years, RxSight's Accumulated Depreciation & Amortization soared by 512.82% in 2023 and then tumbled by 1219.51% in 2024.
- RxSight's Accumulated Depreciation & Amortization (Quarter) stood at $3.9 million in 2020, then rose by 2.56% to $4.0 million in 2021, then fell by 2.5% to $3.9 million in 2022, then grew by 5.13% to $4.1 million in 2023, then dropped by 12.2% to $3.6 million in 2024.
- Its last three reported values are $3.6 million in Q4 2024, $4.1 million for Q4 2023, and $3.9 million during Q4 2022.